Advertisement
Screener

Kite Pharma, Inc. Form D

Kite Pharma, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2013-05-24: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-05-10; Total offering amount $16,420,598.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2013-05-24Rule 506Equity2013-05-10$16,420,598$16,420,598$031